United Kingdom

Immutep Ltd (IMMP.OQ)

IMMP.OQ on NASDAQ Stock Exchange Global Market

8:14pm GMT
Change (% chg)

$0.04 (+2.56%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Marc Voigt

42 2016 Chief Executive Officer, Executive Director

Deanne Miller

39 2016 Chief Operating Officer, General Counsel, Company Secretary

Frederic Triebel

61 2014 Chief Scientific Officer & Chief Medical Officer

Grant Chamberlain

2017 Non-Executive Director

Russell Howard

65 2013 Non-Executive Director